There are only a few hours left to register for tonight’s enLIGHTen Speaker Series. Join us as Ryan Levy, MD, Federico Steiner, MD, and Colleen Gaughan, MD share their expert insights on patient selection and explore their own fascinating ground-glass opacity (GGO) cases using our intraoperative molecular imaging agent, which enables surgeons to #SeeCancerInRealTime. Register now at: https://lnkd.in/enX-gAR8 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
On Target Laboratories
Biotechnology Research
West Lafayette, Indiana 3,309 followers
Our mission is to illuminate cancer intraoperatively so it can be removed completely.
About us
On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue University's Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete surgical resection. Visit our website to learn more about On Target Laboratories and our targeted intraoperative molecular imaging agents.
- Website
-
http://www.ontargetlabs.com
External link for On Target Laboratories
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- West Lafayette, Indiana
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Flourescence Guided Surgery, Intra-operative optical imaging for cancer, Oncology, Surgery, Cancer, Fluorescent Imaging Technology, Intraoperative Sight, Science, Ovarian Cancer, Lung Cancer, Prostate Cancer, and Thoracic Surgery
Locations
-
Primary
1281 Win Hentschel Blvd
West Lafayette, Indiana 47906, US
Employees at On Target Laboratories
Updates
-
#DidYouKnow? In #ThoracicSurgery, localizing pulmonary ground-glass opacities (GGOs) can be challenging. Localization tools such as microcoil and hook wire placement lack precision and may increase procedural time and complications risk. In a study with 20 patients, our intraoperative imaging agent localized 15 of 21 Ground Glass Opacity (GGO) lesions, whereas VATS alone identified 10 of 21 (p=0.05). Learn more about the management of GGO’s at our next enLIGHTen Speaker Series webinar. Register here: https://lnkd.in/enX-gAR8. For more information about our intraoperative molecular imaging agent and related risks, please visit: https://bit.ly/3yr0tVN https://lnkd.in/gE_fiKAN
-
Join our next enLIGHTen Speaker Series on August 26 to hear from Colleen Gaughan, MD, thoracic surgeon for AdventHealth. During this virtual event, Gaughan will discuss her experience with patient selection and present two of her ground-glass opacity (GGO) cases utilizing our intraoperative molecular imaging agent that helps surgeons #SeeCancerInRealTime. Register here: https://lnkd.in/enX-gAR8 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
-
-
We recently visited Anne Arundel Medical Center where we showcased our intraoperative molecular imaging agent at Stryker’s mobile learning truck! To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN To speak with one of our sales representatives, visit: https://lnkd.in/dfr3P9X8
-
-
Meet Federico Steiner, MD, thoracic surgeon at Atlantic Health System. During our next enLIGHTen Speaker Series, Steiner will share his process for patient selection and present on two of his own ground-glass opacity (GGO) cases utilizing our intraoperative molecular imaging agent that helps surgeons #SeeCancerInRealTime. Register here to join us on August 26: https://lnkd.in/enX-gAR8 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
-
-
On Target is attending the Michigan Society of Thoracic and Cardiovascular Surgeons 60th Annual Meeting alongside our partners at Stryker. You can also meet our Great Lakes Regional Sales Manager Julie Tuberson Hall, who will be showcasing our intraoperative molecular imaging agent that helps surgeons #SeeCancerInRealTime. To speak with one of our sales representatives, visit: https://lnkd.in/dfr3P9X8 Learn more about #MSTCVS: https://lnkd.in/dv_FQ7n9
-
Congratulations to Dr. Gary Chmielewski who is bringing innovative care to #SeeCancerInRealTime for his patients! Thank you to Colleen Gaughan, MD for your guidance in proctoring this first case of our intraoperative molecular imaging agent used in conjunction with Stryker 1788 at AdventHealth Orlando.
Happy to share the news of Dr. Gary Chmielewski's first Cytalux case at AdventHealth Orlando. I was honored to proctor him! #Stryker1788 #OnTargetLabs #SeeCancerInRealTime
-
-
Meet Ryan Levy, MD at the next enLIGHTen Speaker Series virtual event on August 26. Dr. Levy, Chief of the Division of Thoracic Surgery at UPMC, will share insights into his patient selection process and delve into two ground glass opacity (GGO) cases utilizing our intraoperative molecular imaging agent that helps surgeons #SeeCancerInRealTime. Register here: https://lnkd.in/enX-gAR8 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
-
-
In Colleen Gaughan, MD's recent AdventHealth Q&A, she shares important facts about #LungCancer, as well as screening and preventative measures. We’re looking forward to hearing more from Dr. Gaughan during our enLIGHTen event on August 26th. To learn about how Dr. Gaughan is utilizing our intraoperative molecular imaging agent that helps surgeons #SeeCancerInRealTime, register here: https://lnkd.in/enX-gAR8
Q&A with AdventHealth: Lung cancer
wftv.com
-
Register now for our next enLIGHTen Speaker Series event on Monday, August 26 at 6 p.m. ET! This virtual event will feature presentations and interactive Q+As with Ryan Levy, MD, Federico Steiner, MD, and Colleen Gaughan, MD as they discuss the current management of GGOs utilizing our intraoperative molecular imaging agent. Register here: https://lnkd.in/enX-gAR8 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
-